Ilab Ultrasound Imaging System, Version 1.3
System, Imaging, Pulsed Echo, Ultrasonic. 510(k) K072517, from Boston Scientific Corp (Fremont, CA). Product code IYO, class 2.
As of Nov 22, 2026, K072517 is an FDA 510(k) held by Boston Scientific Corp, substantially equivalent on Sep 26, 2007 after 19 days, with 1 recall tied to it in FDA's recall database.
- Review time: 19 days
- Recalls: 1
- Cited as a predicate by: 1 device
The iLab™ Ultrasound Imaging System is intended for ultrasound examinations of intravascular pathology. Intravascular ultrasound is indicated in patients who are candidates for transluminal interventional procedures such as angioplasty and atherectomy.
- Immunalysis Amphetamine Elisa for Oral FluidsK051579 · Immunalysis Corporation · Oct 21, 2005
- Ilab Ultrasound Imaging SystemK123535 · Boston Scientific Corp · Jan 15, 2013
| Started | Recall | Status |
|---|---|---|
| Apr 11, 2000 | Z-1693-2008Improperly terminated wires on a component of the iLab Acquisition processor power supply could cause the processor to lock-up or stop, and prolong the patients procedure. | Terminated |
- Evident Vascular™ Guidance SystemK261648 · Evident Vascular, Inc. · Oct 28, 2026
- Accuro XVK262093 · Rivanna Medical, Inc. · Oct 20, 2026
- Lilium one (USM330)K260605 · Lilium Otsuka Co., Ltd. · Oct 16, 2026
- MD-6000S Bladder ScannerK260313 · MEDA Co., Ltd. · Sep 24, 2026
- Accuro 3SK253452 · Rivanna Medical, Inc. · Jul 24, 2026
- ArthurK260190 · ROPCA ApS · Jun 18, 2026
- EdgeFlow UW20K252237 · Edgecare, Inc. · Apr 17, 2026
- Accuro XVK254021 · Rivanna Medical, Inc. · Apr 9, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 7, 2007
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1560
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files